SLC16A3 and neoplasm: In the future, there is a pressing need to proactively explore several avenues: developing therapeutic strategies to enhance immune cell tolerance to lactate, such as upregulating the expression of MCT1 or MCT4, thereby improving the transport and utilization efficiency of lactate within immune cells, ensuring they can maintain normal proliferation, differentiation, and anti-tumor functions even within an acidic environment.